Investigation on Efficacy and Safety of Apixaban in Japanese Elderly Patients: Investigator-Initiated Multicenter Prospective Cohort Study

Trial Profile

Investigation on Efficacy and Safety of Apixaban in Japanese Elderly Patients: Investigator-Initiated Multicenter Prospective Cohort Study

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 19 Dec 2016

At a glance

  • Drugs Apixaban (Primary)
  • Indications Atrial fibrillation
  • Focus Therapeutic Use
  • Acronyms J-ELD AF (CVI ARO 5)
  • Most Recent Events

    • 14 Dec 2016 Status changed from recruiting to active, no longer recruiting.
    • 30 Jun 2016 Planned End Date changed from 31 Aug 2016 to 31 Aug 2017.
    • 14 Dec 2015 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top